Rebecca J. Shaw

Liverpool, ENG CH647TE, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Factor X Concentrate Treatment Schedule and Dosing in Acquired FX Deficiency.

Factor X Concentrate Treatment Schedule and Dosing in Acquired FX Deficiency.

Journal: Hematology reports

Published: December 03, 2024

The Highs and Lows of ADAMTS13 Activity.

The Highs and Lows of ADAMTS13 Activity.

Journal: Journal of clinical medicine

Published: June 18, 2024

Damage-associated cellular markers in the clinical and pathogenic profile of vaccine-induced immune thrombotic thrombocytopenia.

Damage-associated cellular markers in the clinical and pathogenic profile of vaccine-induced immune thrombotic thrombocytopenia.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 19, 2023

Integrating psychology services for patients with thrombotic thrombocytopenic purpura: A specialist centre experience.

Integrating psychology services for patients with thrombotic thrombocytopenic purpura: A specialist centre experience.

Journal: EJHaem

Published: March 15, 2023

Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria.

Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria.

Journal: Vaccine

Published: June 27, 2022

Mind and matter: The neurological complications of thrombotic thrombocytopenic purpura.

Mind and matter: The neurological complications of thrombotic thrombocytopenic purpura.

Journal: British journal of haematology

Published: December 10, 2021

Immunogenic SARS-CoV2 Epitopes Defined by Mass Spectrometry.

Immunogenic SARS-CoV2 Epitopes Defined by Mass Spectrometry.

Journal: bioRxiv : the preprint server for biology

Published: July 27, 2021

In Silico Defined SARS-CoV2 Epitopes May Not Predict Immunogenicity to COVID19.

In Silico Defined SARS-CoV2 Epitopes May Not Predict Immunogenicity to COVID19.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2021

COVID-19 and immunothrombosis: emerging understanding and clinical management.

COVID-19 and immunothrombosis: emerging understanding and clinical management.

Journal: British journal of haematology

Published: June 11, 2021

Intracranial hemorrhage in immune thrombotic thrombocytopenic purpura treated with caplacizumab.

Intracranial hemorrhage in immune thrombotic thrombocytopenic purpura treated with caplacizumab.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 29, 2021

Circulating histones play a central role in COVID-19-associated coagulopathy and mortality.

Circulating histones play a central role in COVID-19-associated coagulopathy and mortality.

Journal: Haematologica

Published: February 05, 2021

Real-world experience with caplacizumab in the management of acute TTP.

Real-world experience with caplacizumab in the management of acute TTP.

Journal: Blood

Published: June 10, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026